{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:50:03Z","timestamp":1754488203833},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/fpc.0b013e32831ebb4b","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T08:14:22Z","timestamp":1232093662000},"page":"121-128","source":"Crossref","is-referenced-by-count":21,"title":["Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors"],"prefix":"10.1097","volume":"19","author":[{"given":"B\u00e1rbara","family":"Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crist\u00f3bal","family":"Gast\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana De","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Fa\u00f1an\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210212","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archpsyc.56.6.557","article-title":"Major depressive disorder in a community-based twin sample: are there different genetic and environmental contributions for men and women?","volume":"56","author":"Bierut","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R2-4-20210212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.metabol.2005.01.006","article-title":"Genetics and genomics of depression","volume":"54","author":"Hamet","year":"2005","journal-title":"Metabolism"},{"key":"R3-4-20210212","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"R4-4-20210212","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bmj.314.7081.646","article-title":"General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants","volume":"314","author":"Martin","year":"1997","journal-title":"Br Med J"},{"key":"R5-4-20210212","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/9.6.927","article-title":"Recent progress in psychiatric genetics \u2013 some hope but no hype","volume":"9","author":"Stoltenberg","year":"2000","journal-title":"Hum Mol Genet"},{"key":"R6-4-20210212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-5618.2002.01203.x","article-title":"Antidepressants and neuroplasticity","volume":"4","author":"D'Sa","year":"2002","journal-title":"Bipolar Disord"},{"key":"R7-4-20210212","doi-asserted-by":"crossref","first-page":"24232","DOI":"10.1074\/jbc.M010418200","article-title":"Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain","volume":"276","author":"Benson","year":"2001","journal-title":"J Biol Chem"},{"key":"R8-4-20210212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/341750","article-title":"Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia","volume":"71","author":"Straub","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R9-4-20210212","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/hmg\/ddh280","article-title":"Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia","volume":"13","author":"Numakawa","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R10-4-20210212","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1046\/j.1460-9568.1999.00887.x","article-title":"Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice)","volume":"11","author":"Knuesel","year":"1999","journal-title":"Eur J Neurosci"},{"key":"R11-4-20210212","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI200420425","article-title":"Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia","volume":"113","author":"Talbot","year":"2004","journal-title":"J Clin Invest"},{"key":"R12-4-20210212","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R13-4-20210212","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1074\/jbc.M508157200","article-title":"Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release","volume":"281","author":"Yagasaki","year":"2006","journal-title":"J Biol Chem"},{"key":"R14-4-20210212","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/schbul\/sbi061","article-title":"Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?","volume":"31","author":"Williams","year":"2005","journal-title":"Schizophr Bull"},{"key":"R15-4-20210212","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2007.05.017","article-title":"Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis","volume":"96","author":"Li","year":"2007","journal-title":"Schizophrenia Research"},{"key":"R16-4-20210212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000101961","article-title":"DTNBP1 (dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3\u2032 end of the gene","volume":"64","author":"Duan","year":"2007","journal-title":"Human Heredity"},{"key":"R17-4-20210212","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpsychires.2007.02.005","article-title":"Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction","volume":"42","author":"Vilella","year":"2008","journal-title":"J Psychiatr Res"},{"key":"R18-4-20210212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2007.11.031","article-title":"A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis","volume":"431","author":"Corvin","year":"2008","journal-title":"Neurosci Lett"},{"key":"R19-4-20210212","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/497703","article-title":"Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios","volume":"77","author":"Fallin","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R20-4-20210212","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.biopsych.2005.01.018","article-title":"Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1)","volume":"57","author":"Raybould","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R21-4-20210212","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1176\/ajp.2006.163.9.1636","article-title":"Association of the dysbindin gene with bipolar affective disorder","volume":"163","author":"Breen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R22-4-20210212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbj033","article-title":"Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology","volume":"32","author":"Craddock","year":"2006","journal-title":"Schizophr Bull"},{"key":"R23-4-20210212","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neulet.2007.03.037","article-title":"Dysbindin gene variants are associated with bipolar I disorder in a Korean population","volume":"418","author":"Joo","year":"2007","journal-title":"Neurosci Lett"},{"key":"R24-4-20210212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.fpc.0000236330.03681.6d","article-title":"Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy","volume":"17","author":"Pae","year":"2007","journal-title":"Pharmacogenetics and Genomics"},{"key":"R25-4-20210212","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.30064","article-title":"The dysbindin gene in major depression: an association study","volume":"129","author":"Zill","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R26-4-20210212","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pnpbp.2007.09.002","article-title":"Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder","volume":"32","author":"Kim","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R27-4-20210212","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.jcp.0000095350.32154.73","article-title":"5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study","volume":"23","author":"Arias","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R28-4-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.ypg.0000107928.32051.11","article-title":"Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment","volume":"14","author":"Lee","year":"2004","journal-title":"Psychiatr Genet"},{"key":"R29-4-20210212","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/07853890600551045","article-title":"Pharmacogenomics and antidepressant drugs","volume":"38","author":"Binder","year":"2006","journal-title":"Ann Med"},{"key":"R30-4-20210212","article-title":"Structured clinical interview for DSM-III-R","author":"Spitzer","year":"1990"},{"key":"R31-4-20210212","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R32-4-20210212","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0033291700021644","article-title":"Scaled version of the general health questionnaire","volume":"9","author":"Goldberg","year":"1979","journal-title":"Psychol Med"},{"key":"R33-4-20210212","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004714-199608000-00006","article-title":"A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation","volume":"16","author":"Baumann","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"R34-4-20210212","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R35-4-20210212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(95)00347-9","article-title":"Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites","volume":"675","author":"Olesen","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R36-4-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R37-4-20210212","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21(2)","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"R38-4-20210212","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1088\/0031-9155\/50\/20\/006","article-title":"Monte Carlo simulation and scatter correction of the GE advance PET scanner with SimSET and Geant4","volume":"50","author":"Barret","year":"2005","journal-title":"Phys Med Biol"},{"key":"R40-4-20210212","article-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"R41-4-20210212","article-title":"The genetics of mood disorders","author":"Tsuang","year":"1990"},{"key":"R42-4-20210212","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression","volume":"29","author":"Hasler","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R43-4-20210212","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/427925","article-title":"Linkage disequilibrium patterns and tagSNP transferability among European populations","volume":"76","author":"Mueller","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R44-4-20210212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152707780363267","article-title":"The NMDA receptor as a therapeutic target in major depressive disorder","volume":"6","author":"Pittenger","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R45-4-20210212","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1523\/JNEUROSCI.15-06-04687.1995","article-title":"Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus","volume":"15","author":"Cameron","year":"1995","journal-title":"J Neurosci"},{"key":"R46-4-20210212","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0306-4522(95)00259-L","article-title":"Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors","volume":"69","author":"Magarinos","year":"1995","journal-title":"Neuroscience"},{"key":"R47-4-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004850-200505000-00005","article-title":"Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism","volume":"20","author":"Kato","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"R48-4-20210212","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0893-133X(00)00132-9","article-title":"Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression","volume":"23","author":"Pollock","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R49-4-20210212","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004714-200002000-00021","article-title":"Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene","volume":"20","author":"Zanardi","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R50-4-20210212","first-page":"53","article-title":"Remission versus response: the new gold standard of antidepressant care","volume":"65","author":"Keller","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R51-4-20210212","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2174\/138945006779025419","article-title":"Serotonin transporter gene variants and behavior: a comprehensive review","volume":"7","author":"Serretti","year":"2006","journal-title":"Curr Drug Targets"},{"key":"R52-4-20210212","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1176\/appi.ajp.163.3.532","article-title":"Dysbindin genotype and negative symptoms in schizophrenia","volume":"163","author":"DeRosse","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R53-4-20210212","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neures.2006.06.009","article-title":"Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population","volume":"56","author":"Tochigi","year":"2006","journal-title":"Neurosci Res"},{"key":"R54-4-20210212","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1017\/S003329170200541X","article-title":"Neuroticism, major depression and gender: a population-based twin study","volume":"32","author":"Fanous","year":"2002","journal-title":"Psychol Med"},{"key":"R55-4-20210212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1086\/345463","article-title":"Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families","volume":"72","author":"Schwab","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R56-4-20210212","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/379928","article-title":"The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease","volume":"73","author":"Van Den Bogaert","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R57-4-20210212","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1176\/appi.ajp.162.7.1243","article-title":"\u2018A gene for\u2026\u2019: the naure of gene action in psychiatric disorders","volume":"162","author":"Kendler","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R58-4-20210212","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1176\/ajp.2006.163.7.1138","article-title":"Reflections on the relationship between psychiatric genetics and psychiatric nosology","volume":"163","author":"Kendler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R59-4-20210212","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.mp.4001690","article-title":"Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia","volume":"10","author":"Fan","year":"2005","journal-title":"Mol Psychiatry"},{"key":"R60-4-20210212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.b.30104","article-title":"Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders","volume":"133","author":"Lasky-Su","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatry Genet"},{"key":"R61-4-20210212","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.biopsych.2005.01.030","article-title":"The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis","volume":"57","author":"Lopez Leon","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R62-4-20210212","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/hmg\/ddi199","article-title":"Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression","volume":"14","author":"Bray","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R63-4-20210212","article-title":"The history and geography of human genes","author":"Cavalli","year":"1994"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-200902000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:49:30Z","timestamp":1618364970000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200902000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32831ebb4b","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}